GENSCRIPT BIO(01548) - 2025 Q4 - Earnings Call Transcript
GENSCRIPT BIO(HK:01548)2026-03-16 00:17Genscript Biotech (SEHK:01548) H2 2025 Earnings call March 15, 2026 07:15 PM ET Company ParticipantsAixi Bai - General ManagerAllen Guo - CEOJosie Zhou - Interim CFOPhil Zhou - CFORay Chen - President of GenScript Life Science GroupSherry Shao - Rotating CEOYang Huang - Executive DirectorConference Call ParticipantsLaurence Tam - AnalystLinda Xu - AnalystOperatorGood day, thank you for standing by. Welcome to GenScript 2025 annual results conference call. At this time, all participants are in a listen-only ...